Improving Cystic Fibrosis Patient Outcomes through Research
In this Research Insights video, Gregory Omlor, MD, director of pulmonary medicine at Akron Children's, discussed a study being conducted by his staff that compares the relative effectiveness of two delivery systems for Tobramycin, a medication used to treat patients with cystic fibrosis.
While we are ranked among the best children's hospitals in the country, it's our compassionate approach to treatment that makes us truly exceptional.
Through a combination of revolutionary treatments and extraordinary patient experiences, our care does more than heal. It brings the entire family
together for emotional support and understanding across multiple locations to reach you in the community where you live.